Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Nature Structural Biology

• Publication date

  2000-01-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/10658PMID 10404214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Oncogene].

  2019cited by this paper
• Young Investigator Award Lecture. Structures of larger proteins, protein-ligand and protein-DNA complexes by multidimensional heteronuclear NMR.

  2009cited by this paper
• Molecular insights into PEBP2/CBFβ-SMMHC associated acute leukemia revealed from the structure of PEBP2/CBFβ

  1999cited by this paper
• Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias.

  1999cited by this paper
• Molecular insights into PEBP2/CBF beta-SMMHC associated acute leukemia revealed from the structure of PEBP2/CBF beta.

  1999cited by this paper
• Mutual activation of Ets‐1 and AML1 DNA binding by direct interaction of their autoinhibitory domains

  1999cited by this paper
• The Leukemic Protein Core Binding Factor β (CBFβ)–Smooth-Muscle Myosin Heavy Chain Sequesters CBFα2 into Cytoskeletal Filaments and Aggregates

  1998cited by this paper
• Cytoplasmic Sequestration of the Polyomavirus Enhancer Binding Protein 2 (PEBP2)/Core Binding Factor α (CBFα) Subunit by the Leukemia-Related PEBP2/CBFβ-SMMHC Fusion Protein Inhibits PEBP2/CBF-Mediated Transactivation

  1998cited by this paper
• Structure of NF-κB p50 homodimer bound to a κB site

  1998cited by this paper
• Three-dimensional structure of the Stat3β homodimer bound to DNA

  1998cited by this paper
• Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA.

  1998cited by this paper
• Solution structure of the core NFATC1/DNA complex.

  1998cited by this paper
• Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA

  1998cited by this paper
• The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates.

  1998cited by this paper
• Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation.

  1998cited by this paper
• A simple screening for mutant DNA binding proteins: application to murine transcription factor PEBP2alpha subunit, a founding member of the Runt domain protein family.

  1997cited by this paper
• The solution structure of a specific GAGA factor–DNA complex reveals a modular binding mode

  1997cited by this paper
• Oncogenic transcription factors in the human acute leukemias.

  1997cited by this paper
• Improvements and extensions in the conformational database potential for the refinement of NMR and X-ray structures of proteins and nucleic acids.

  1997cited by this paper
• Differentiation dependent expression and distinct subcellular localization of the protooncogene product, PEBP2β/CBFβ, in muscle development

  1997cited by this paper
• Redox Regulation of the DNA Binding Activity in Transcription Factor PEBP2

  1997cited by this paper
• Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia

  1997cited by this paper
• Functional Dissection of the α and β Subunits of Transcription Factor PEBP2 and the Redox Susceptibility of Its DNA Binding Activity*

  1996cited by this paper
• AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR

  1996cited by this paper
• Biochemical and Biophysical Properties of the Core-binding Factor α2 (AML1) DNA-binding Domain*

  1996cited by this paper
• Structure of the NF-kappa B p50 homodimer bound to DNA.

  1995cited by this paper
• Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF

  1995cited by this paper
• Structure of the NF-κB p50 homodimer bound to DNA

  1995cited by this paper
• Structure of NF-kappa B p50 homodimer bound to a kappa B site.

  1995cited by this paper
• Functional domains of the t(8;21) fusion protein, AML-1/ETO.

  1995cited by this paper
• The immunoglobulin fold. Structural classification, sequence patterns and common core.

  1994cited by this paper
• Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

  1994cited by this paper
• The impact of direct refinement against three-bond HN-C alpha H coupling constants on protein structure determination by NMR.

  1994cited by this paper
• Acute myeloid leukemia with Inv (16) produces a chimeric transcription factor with a myosin heavy chain tail.

  1994cited by this paper
• Molecular Cloning and Characterization of PEBP2β, the Heterodimeric Partner of a Novel Drosophila runt-Related DNA Binding Protein PEBP2α

  1993cited by this paper
• A calculation strategy for the structure determination of symmetric demers by 1H NMR

  1993cited by this paper
• Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha.

  1993cited by this paper
• Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor

  1993cited by this paper
• Recognition of errors in three‐dimensional structures of proteins

  1993cited by this paper
• Methodological advances in protein NMR

  1993cited by this paper
• Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons

  1991cited by this paper
• Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer

  1990cited by this paper
• Blood.

  1989cited by this paper
• Ribbon models of macromolecules

  1987cited by this paper

• Cbfβ: A key regulator in skeletal stem cell differentiation, bone development, and disease

  2025cites this paper
• RUN(X) out of blood: emerging RUNX1 functions beyond hematopoiesis and links to Down syndrome

  2023cites this paper
• Clonal hematopoiesis of indeterminate potential in the companion dog

  2022cites this paper
• Molecular basis of haematological disease caused by inherited or acquired RUNX1 mutations.

  2022cites this paper
• RUNX1 Dosage in Development and Cancer

  2020cites this paper
• RUNX family: Oncogenes or tumor suppressors

  2019cites this paper
• Loss of Filamin A leads to heart failure in zebrafish

  2019cites this paper
• RUNX transcription factors: orchestrators of development

  2019cites this paper
• Transcriptional control of blood cell emergence

  2019cites this paper
• Characterisation of an aptamer against the Runt domain of AML1 (RUNX1) by NMR and mutational analyses

  2018cites this paper
• Regulation of RUNX1 dosage is crucial for efficient blood formation from hemogenic endothelium

  2018cites this paper
• RUNX1 Control of Mammary Epithelial and Breast Cancer Cell Phenotypes

  2017cites this paper
• Selective base excision repair of DNA damage by the non‐base‐flipping DNA glycosylase AlkC

  2017cites this paper
• Conjugation of two RNA aptamers improves binding affinity to AML1 Runt domain

  2017cites this paper
• Structure and Biophysics of CBFβ/RUNX and Its Translocation Products.

  2017cites this paper
• Novel Mutation of the RUNX2 Gene in Patients with Cleidocranial Dysplasia

  2017cites this paper
• Protein dynamics and function from solution state NMR spectroscopy

  2016cites this paper
• New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins

  2016cites this paper
• Kinetic and Thermodynamic Analyses of Interaction between a High-Affinity RNA Aptamer and Its Target Protein.

  2016cites this paper
• X-Signal amplification by Runt mediated antagonism of Groucho in Drosophila

  2015cites this paper
• A role for CBFβ in mammary gland development and breast carcinogenesis

  2014cites this paper
• CBFβ and the Leukemogenic Fusion Protein CBFβ‐SMMHC Associate With Mitotic Chromosomes to Epigenetically Regulate Ribosomal Genes

  2014cites this paper
• Core Binding Factor β (CBFβ) Is Retained in the Midbody During Cytokinesis

  2014influential citation
• Study of molecular mechanisms implicated in the TGF-beta oncogenic effect in Glioma

  2013cites this paper
• Investigating RUNX transcription factors in mammary gland development and breast cancer

  2013cites this paper
• The Runt domain of AML1 (RUNX1) binds a sequence-conserved RNA motif that mimics a DNA element

  2013influential citation
• Solution structure of a DNA mimicking motif of an RNA aptamer against transcription factor AML1 Runt domain.

  2013cites this paper
• Expression and stability of wild-type and mutant RUNX1 protein isoforms in T-cell acute lymphoblastic leukemia

  2013influential citation
• implications for mechanisms of pathogenesis familial platelet disorder with predisposition to acute myelogenous leukemia: In vitro analyses of known and novel RUNX1/AML1 mutations in dominant

  2013cites this paper
• RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.

  2012cites this paper
• A catalogue of eukaryotic transcription factor types, their evolutionary origin, and species distribution.

  2011cites this paper
• A eukaryotic-like interaction of soluble cyanobacterial sensory rhodopsin transducer with DNA.

  2011cites this paper
• RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making.

  2011cites this paper
• Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.

  2010cites this paper
• Activated leukemic oncogenes responsible for neoplastic transformation of hematopoietic cells

  2010cites this paper
• Runx1 binds as a dimeric complex to overlapping Runx1 sites within a palindromic element in the human GM-CSF enhancer

  2010cites this paper
• Antibody Engineering for Biosensor Applications

  2010cites this paper
• Mutation of AML1/ R UNX1 and Leukemogenesis

  2010cites this paper
• Analysis of senescence-like growth arrest induced by RUNX1 and its fusion derived oncoproteins

  2008cites this paper
• Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant‐negative, or hypomorphic alleles

  2007cites this paper
• Transcriptional dysregulation during myeloid transformation in AML

  2007cites this paper
• Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDS.

  2006cites this paper
• Normal and transforming functions of RUNX1: A perspective

  2006cites this paper
• Multiple mapping method: A novel approach to the sequence‐to‐structure alignment problem in comparative protein structure modeling

  2006cites this paper
• A mutation in the S-switch region of the Runt domain alters the dynamics of an allosteric network responsible for CBFbeta regulation.

  2006cites this paper
• Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndrome.

  2005cites this paper
• Filamin A-Bound PEBP2β/CBFβ Is Retained in the Cytoplasm and Prevented from Functioning as a Partner of the Runx1 Transcription Factor

  2005cites this paper
• Trinucleotide Repeats (TNRs): DNA-Bindungssubstrate für Wildtyp und mutiertes p53 und Modulatoren der p53-abhängigen Transkription

  2005cites this paper
• Molecular pathways of proprioceptive dorsal root ganglion (DRG) sensory neuron specification

  2005cites this paper
• Biological implications of filamin A-bound PEBP2beta/CBFbeta retention in the cytoplasm.

  2005cites this paper
• AML1B transcriptional repressor function is impaired by the Flt3‐internal tandem duplication

  2005cites this paper
• Oct-1 Counteracts Autoinhibition of Runx2 DNA Binding To Form a Novel Runx2/Oct-1 Complex on the Promoter of the Mammary Gland-Specific Gene β-casein

  2005cites this paper
• MODBASE, a database of annotated comparative protein structure models, and associated resources

  2004cites this paper
• Overview of Protein Structural and Functional Folds

  2004cites this paper
• Oncogenic potential of the RUNX gene family: ‘Overview’

  2004cites this paper
• Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia

  2004cites this paper
• Familial Mutations of the Transcription Factor RUNX1 (AML1, CBFA2) Predispose to Acute Myeloid Leukemia

  2004cites this paper
• Novel loss‐of‐function mutations of the haematopoiesis‐related transcription factor, acute myeloid leukaemia 1/runt‐related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome

  2004cites this paper
• Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.

  2004cites this paper
• High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.

  2004influential citation
• Functional analysis of RUNX2 mutations in cleidocranial dysplasia: novel insights into genotype-phenotype correlations.

  2003cites this paper
• Structural and functional characterization of Runx1, CBF beta, and CBF beta-SMMHC.

  2003cites this paper
• Structural and functional characterization of Runx1, CBFβ, and CBFβ-SMMHC

  2003cites this paper
• Comparative protein structure modeling by iterative alignment, model building and model assessment.

  2003cites this paper
• Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia.

  2003cites this paper
• The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications.

  2003cites this paper
• Energetic Contribution of Residues in the Runx1 Runt Domain to DNA Binding*

  2003cites this paper
• Runx3 knockouts and stomach cancer

  2003cites this paper
• Mutagenesis of the Runt Domain Defines Two Energetic Hot Spots for Heterodimerization with the Core Binding Factor β Subunit*

  2003cites this paper
• Mutations in the RUNX2 gene in patients with cleidocranial dysplasia

  2002cites this paper
• In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.

  2002cites this paper
• Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations.

  2002cites this paper
• The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.

  2002cites this paper
• Core-binding factors in haematopoiesis and leukaemia

  2002cites this paper
• Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7

  2002cites this paper
• Runx1/AML1 in leukemia: disrupted association with diverse protein partners.

  2002cites this paper
• Studies on the core binding factor complex in patients with acute myeloid leukaemia.

  2002cites this paper
• Core binding factor genes and human leukemia.

  2002influential citation
• Isolation and characterization of runxa and runxb, zebrafish members of the runt family of transcriptional regulators.

  2002cites this paper
• DNA recognition by the RUNX1 transcription factor is mediated by an allosteric transition in the RUNT domain and by DNA bending.

  2002cites this paper
• Histone Acetylation in Vivo at the Osteocalcin Locus Is Functionally Linked to Vitamin D-dependent, Bone Tissue-specific Transcription*

  2002cites this paper
• Structure function of Cbfa proteins

  2001cites this paper
• DNA-binding by Ig-fold proteins

  2001cites this paper
• DNA Recognition by NFκB and STAT Transcription Factors

  2001cites this paper
• The Role of the AML1 Transcription Factor in Leukemogenesis

  2001cites this paper
• Transcription factors: global and detailed views.

  2001cites this paper
• Dimerization with PEBP2β protects RUNX1/AML1 from ubiquitin–proteasome‐mediated degradation

  2001cites this paper
• Chloride binding by the AML1/Runx1 transcription factor studied by NMR

  2001cites this paper
• Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain.

  2001cites this paper
• Identification of novel CBFA1/RUNX2 mutations causing cleidocranial dysplasia

  2001cites this paper
• AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML

  2001cites this paper
• Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.

  2001cites this paper
• The leukemia-associated AML1 (Runx1)–CBFβ complex functions as a DNA-induced molecular clamp

  2001cites this paper
• Crystallization and preliminary studies of the DNA-binding runt domain of AML1.

  2001cites this paper
• Assessment of Gene Regulation by Bone Morphogenetic Protein 2 in Human Marrow Stromal Cells Using Gene Array Technology

  2001cites this paper
• Point Mutations of the RUNX1/AML1 Gene in Sporadic and Familial Myeloid Leukemias

  2001cites this paper
• Crystallization and preliminary X-ray analyses of quaternary, ternary and binary protein-DNA complexes with involvement of AML1/Runx-1/CBFalpha Runt domain, CBFbeta and the C/EBPbeta bZip region.

  2001cites this paper
• Functional mutagenesis of AML1/RUNX1 and PEBP2β/CBFβ define distinct, non-overlapping sites for DNA recognition and heterodimerization by the runt domain

  2001cites this paper
• Identification of the regions involved in DNA binding by the mouse PEBP2α protein

  2000cites this paper
• Function of CBFbeta/Bro proteins.

  2000cites this paper